BSN Capital Partners’s Salesforce CRM Stock Holding History

BSN Capital Partners’s Portfolio CRM Stock Details CRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-191,000	Closed	-$44M	–	8
2023 Q4	$44M	Buy	+191,000	New	+$43.2M	2.38%	9

Other funds holding CRM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BSN Capital Partners's CRM Position: Q1 2024 in Review

BSN Capital Partners sold out of Salesforce (CRM) in Q1 2024, closing a stake of 191,000 shares — an estimated $44M sold.

BSN Capital Partners first reported a position in CRM in Q4 2023 and held it in 1 quarter. The position peaked at $44M in Q4 2023. 2,763 funds tracked by Wall St. Rank hold CRM as of Q1 2024.

BSN Capital Partners reported no remaining Salesforce position as of Q1 2024 after selling out during the quarter.
BSN Capital Partners sold 191,000 Salesforce shares in Q1 2024, an estimated $44M.
BSN Capital Partners first reported a position in Salesforce in Q4 2023 and held it in 1 quarter.
BSN Capital Partners's Salesforce position peaked at $44M in Q4 2023.
2,763 funds tracked by Wall St. Rank held Salesforce as of Q1 2024.

Based on BSN Capital Partners's 13F filing for Q1 2024, filed 16 Apr 2024.